MediSafe Wins First Prize at Health 2.0’s Traction Startup Championship Competition

SANTA CLARA, Calif.--MediSafe, the top-rated and cloud-synced medication management platform has won first prize in this year’s Traction: Health 2.0’s Startup Championship. As the first mobile solution to sync mobile device medication reminders between family members & caregivers, MediSafe has been identified as a leader in the mHealth industry.

Traction is part of Health 2.0’s Annual Fall Conference in Santa Clara, exhibiting innovative digital health solutions for both providers and consumers. Traction is not a pre-seed contest; rather the judges looked for companies scouting a Series A in the $2 - 12 M ranges. “We are so excited to win this competition against such worthy opponents,” said Omri Shor, MediSafe’s co-founder and CEO, “having started MediSafe to help our father avoid serious problems with taking his insulin, we’re all about protecting family and friends in taking their medication. This is such an honor.”

Close to 100 companies applied to this competition, and MediSafe showcased their traction in front industry leading investors to become the winner in the consumer facing track. Health 2.0 has more than 2,000 attendees and over 300 technology companies ranging Fortune 500 companies to bootstrapped startups making this event a plethora of expertise and innovation. MediSafe has evolved into a true platform offering medication adherence solutions on Android (including the Android smartwatch) and Apple devices, expanding to a soon-to-be released web platform, text, email and connectivity to wearables & connected devices. In addition to this award, MediSafe won Qualcomm Venture’s fourth annual QPrize 2014 international investment competition, at Bloomberg’s “Next Big Thing Summit” in Sausalito, California.

MediSafe has been downloaded for free in Google Play and the iTunes App Store over 900,000 times; reminded users to take over 65 million doses and been viewed by users hundreds of millions of times. Its users have an average medication adherence rate of 86%, compared to the 50% average adherence figure for the general population cited by both the World Health Organization (WHO) and the Centers for Disease Control (CDC).

About MediSafe

MediSafe is the leading medication management platform – connecting patients and health providers to improve health outcomes and better understand how people take medication. Inspired by the accidental insulin overdose of its co-founders’ father, MediSafe’s intuitive, singularly designed mobile app – now the most downloaded and highest rated in its category – was first to sync medication reminders between devices of families and caregivers. The MediSafe platform now includes web and SMS sync via branded solutions with pharmaceutical companies, HMOs, pharmacies, electronic medical/health records companies (EMR, EHR) and more. MediSafe also aggregates anonymous patient behavior data for pharmaceutical and healthcare companies, serving as a bridge between patients and health providers, improving health outcomes while benefiting all stakeholders across the healthcare ecosystem. MediSafe’s App can be downloaded from both Google Play and iTunes. For more information, visit www.MediSafeProject.com.

About Health 2.0

Health 2.0 promotes, showcases, and catalyzes new technologies in health care through a worldwide series of conferences, code-a-thons, prize challenges, and leading market intelligence. Visit www.health2con.com for more info.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."